First Thirty

First Thirty is a London-based venture capital firm investing in early-stage companies that create, protect and measure biological quality. The firm leads at pre-seed and seed and follows on at pre-Series A and Series A, with focus areas spanning biological intelligence, quality optimisation and preservation, verification and market infrastructure. It backs companies across the UK, Europe, the United States and opportunistically globally, with sector exposure in agriculture, food, nutrition, climate, biotechnology, infrastructure and sustainability.